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E3 SUMO-protein ligase NSE2ABSTRACT
Objective: To verify possible relations between 5ʹ-nucleotidase, xanthine oxidase to E3
small ubiquitin-like modiﬁer-protein ligase non structural maintenance of chromosomes
elements 2 in sera patients with kidney stones and to evaluate the possibility of a new
biomarker for the evaluation of kidney damage.
Methods: A sixty patients with known kidney stones who appeared the government health
clinics in Kuantan–Pahang and ﬁfty apparently healthy were taken as control group. The 5ʹ-
nucleotidase, xanthine oxidase and other biochemical parameters were measured by color-
imetric tests. The serum NSMCE2 were measured by enzyme linked immunosorbent assay.
Results: The mean serum xanthine oxidase [(39.98 ± 19.70) IU/L] and ecto-5ʹ-nucleo-
tidase activity (40.03 ± 9.53 IU/L) were signiﬁcantly higher than the controls' levels of
(18.04 ± 6.26) and (16.06 ± 4.61) IU/L respectively. There were 85.00% and 83.33%, of
patients with kidney stones who had abnormal ecto-5ʹ-nucleotidase activity and uric acid
respectively while xanthine oxidase activity was less sensitive 58.33%.
Conclusions: The present study suggests that the increase in serumof xanthine oxidase,ecto-
5ʹ-nucleotidase activities E3 small ubiquitin-like modiﬁer-protein ligase NSE2 concentration
can be used as biomarkers for diagnosis of kidney damage in patients with kidney stone, also
in developments of change DNA damage and inﬂammation disorders in these patients.1. Introduction
A kidney stone is a small particles, generally made up of
calcium crystals, that formed inside the kidney wherever urine
collects. The stone commonly reasons different problem till it
reach to the ureter, the tube that drains the kidney into the
bladder, and reasons an obstacle, decreasing urine from draining
out of the kidney and frequently causing severe pain. The stonesare made of mineral and acid salts. Frequently, stones form
when the urine come to be concentrated, permitting minerals to
crystallize and stick together [1].
Small ubiquitin-like modiﬁer (SUMO) proteins are a family
of major proteins belongs to the ubiquitin and ubiquitin-like
protein family [2]. Similar to ubiquitin, SUMO is produced as
soon as the last four amino acids of the C-terminus have been
cleaved off to format an isopeptide bond between the C-
terminal glycine residue of SUMO and lysine on the target
protein. In contrast to ubiquitination, sumoylation does not
support the degradation of proteins but instead changes
different functional parameters of proteins, depending on the
protein substrate in question. These parameters consist of but
are not limited to properties such as subcellular localization,
protein partnering, and DNA-binding and/or transactivation
roles of transcription features [3,4].an open access article under the CC BY-NC-ND
Table 1




General check up 100
Non-speciﬁc symptoms 10
Benign prostatic hyperplasia 0
Table 2






Age (year) 52.42 ± 10.19 50.27 ± 8.21
Hb (g/dL) 12.05 ± 1.40 12.88 ± 0.69
PCV (%) 37.45 ± 4.92 38.88 ± 3.00
WBC (1 × 103 cell/mL) 6.88 ± 0.34 6.17 ± 0.44
Serum urea (mg/dL) 40.25 ± 7.57 37.89 ± 8.36
Serum protein (g/dL) 7.65 ± 0.43 7.68 ± 0.32
Serum uric acid (mg/dL) 6.90 ± 0.94* 5.32 ± 0.33
Serum albumin (g/dL) 4.39 ± 0.58 4.61 ± 0.57
Serum globulin (g/dL) 3.26 ± 0.77 3.07 ± 0.67
Albumin/globulin ratio 1.47 ± 0.55 1.62 ± 0.59
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adenosine monophosphate (AMP) to adenosine, and operated as a
key to switch on adenosine signaling via the P1 receptors [5].
Serum ecto-5ʹ-nucleotidase has a signiﬁcant role in regulation
of purine nucleotide metabolism, then stimulation of this
pathway happens with a depletion of adenosine triphosphate, an
inhibitor of this enzyme, and an increase of inosine
monophosphate and AMP, substrates for this enzyme. On the
other hand, another study indicated that plasma ecto-5ʹ-
nucleotidase may not inﬂuence intracellular nucleotide
degradation [6]. It is an central membrane glycoprotein existing
as an ectoenzyme in a different of mammalian cells, hydrolyzes
5ʹ-nucleotides to their corresponding nucleosides [5]. Adenosine
has an important role in the kidney, such as preserves the
kidney structure and defends from ischemia, arteriolar
vasoconstriction in the external cortex and vasodilatation in the
cortex and medulla, inhibition of renin release, and important
role in electrolyte transport through the proximal tubules [7].
Xanthine oxidase catalyzes the oxidation of hypoxanthine to
xanthine and xanthine to uric acid, which performs as a secondary
product in a superoxide molecule [8]. The metabolic reactions of
xanthine oxidase have a broad effect cellular protection from
toxic complexes and also general protection like innate
immunity [9]. Uric acid is the ﬁnale product of purine
metabolism in human. Hyperuricemia can be the result of
increased uric acid production or reduced excretion. At all cause
for reduction glomerular ﬁltration, tubular excretion or increased
reabsorption would result in an elevated serum uric acid [10].
This study aimed to assess the correlation of serum xanthine
oxidase and ecto-5ʹ-nucleotidase activities to NSMCE2 patients
with kidney stones and assess the possibility of a new biomarker
for the evaluation of kidney damage.
2. Materials and methods
2.1. Patients collection and storage of samples
A total of sixty patients with kidney stones and ﬁfty healthy
as control were comprised in the study. These patients were
hospitalized at government health clinics in Kuantan–Pahang.
Five milliliter of blood was collected and it was allowed to clot
for 10–15 min. Serum was removed after centrifuged and
separated into two parts the ﬁrst to measure the biochemical
parameters and the other part was stored at −20 C till the time
of NSMCE2 assay. The International Islamic University
Malaysia, Research Ethics Committee operates in according to
Declaration of Helsinki International Conference of Harmoni-
zation Good Clinical Practice Guidelines, Malaysia Good
Clinical Practice Guidelines and Council for International Or-
ganization of Medical Sciences, International Ethical Guide-
lines, no. IIUM/305/14/11/2/IREC 300 on October 2014.
2.1.1. Exclusion criteria
Patients suffering from major infections like HIV, type 2
diabetes mellitus, diabetic nephropathy, heart disease, history of
alcohol intake, taking potent antioxidant, and pregnant females
were excluded from the current study.
2.1.2. Inclusion criteria
Patients of kidney stones only attending outpatient department
and admitted in the ward of urology, Hospital Tengku AmpuanAfzan, who agreed to participate in the study were included.
Medical history, standard physical examination, and test of
biochemical parameters (blood sugar, urea, creatinine, protein,
albumin, sodium, potassium and chloride) listed in Table 1.
2.2. Determination of serum protein, NSMCE2, ecto-5ʹ-
nucleotidase, xanthine oxidase and other biochemical
factors
Total protein concentration was determined by Lowry's method
[11]. Serum albumin concentration was determined by bromocresol
green binding using Randox kit. Serum globulin was measured
mathematically from the subtraction albumin concentration from
that of total protein. The concentration of albumin divided by the
concentration of globulin was expressed as albumin to globulin
ratio. Ecto-5ʹ-nucleotidase activity was measured in serum
according to Wood and Williams's method [12]. Xanthine oxidase
activity was determined by the method of Ackermann method [13].
The serum uric acid and levels were measured by
spectrophotometric methods. The serum NSMCE2 were measured
by enzyme linked immunosorbent assay (Cusabio Biotech Com.).
2.3. Statistical analysis
Data were analyzed by using a statistics software package
(SPSS for Windows v.21.0). All groups showed normal distri-
bution, so that parametric statistical methods were used to
analysis the data. One-way ANOVA test was performed. Results
are presented as means ± SD.
3. Results
3.1. Comparison of demographic, hematological data
and biochemical parameters in studied groups
Two groups were included in this study: Group 1 consisted of
sixty men suffering from kidney stones (The mean age of the
Table 3
















Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range
Patients
group
40.03 ± 9.53* 25.33–59.54 0.53 ± 0.13* 0.30–0.79 39.98 ± 19.70* 12.91–80.56 0.52 ± 0.26* 0.17–1.16 80.41 ± 8.45† 70.04–107.81
Control
group
16.06 ± 4.61 5.55–29.77 0.21 ± 0.07 0.07–0.39 18.04 ± 6.26 6.45–30.00 0.24 ± 0.11 0.05–0.44 74.63 ± 4.00 63.80–82.80
*: P < 0.001; †: P < 0.01.
Figure 1. Values of ecto-5ʹ-nucleotidase, xanthine oxidase activities, speciﬁc activities (a–d) and NSMCE2, uric acid (e, f) in patients and control group.
Table 4
The sensitivity of the biochemical test for patients with kidney stones.
Test Sensitivity (%)
Ecto-5ʹ-nucleotidase activity  25.28 IU/L 85.00
Ecto-5ʹ-nucleotidase speciﬁc
activities
 0.35 IU/mg 88.33
Xanthine oxidase activity  30.56 IU/L 58.33
Xanthine oxidase speciﬁc
activities
 0.46 IU/mg 55.00
Serum uric acid  5.98 mg/dL 83.33
NSMCE2  82.63 pg/mL 41.67
Table 5
Correlation between E3 SUMO-protein ligase NSE2 (NSMCE2) with
several biochemical parameters in patients and control groups (pg/mL).












0.71 0.01 0.23 N.S
Xanthine oxidase
activity (IU/L)
0.74 0.01 0.19 N.S
Uric acid (mg/dL) 0.62 0.01 0.10 N.S
Globulin (g/dL) 0.70 0.01 0.39 N.S
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control men with mean age (50.27 ± 8.21) years. All patients
underwent kidney ultrasound screening through ultra-
sonographer. The abdominal ultrasound investigation was done
for several reasons (Table 1).
Hematological parameters: Hb, packed-cell volume (PCV)
and white blood cell (WBC) count in two groups included in this
study according to age were evaluated (Table 2). As the results
in Table 2 showed there was a non-signiﬁcant different
(P > 0.05) in the mean value of erythrocytes hemoglobin, PCV
and WBC account between patients group in comparison with
control group. Meanwhile, serum urea level, protein, albumin,
globulin and albumin/globulin ratio non-signiﬁcantly changed
(P > 0.05) in patients group, when they were compared with
control group (Table 2).
3.2. Serum, ecto-5ʹ-nucleotidase, xanthine oxidase,
NSMCE2 and other biochemical factors
The activates and speciﬁc activities of serum ecto-5ʹ-nucle-
otidase and xanthine oxidase showed a highly signiﬁcant in-
crease (P < 0.001) in patients group compared to control group,
(Table 3 and Figure 1). The present study showed that mean
levels of sera NSMCE2 have a signiﬁcantly increase (P < 0.01)
in patients group compared to control group as shown in
Table 3. Serum NSMCE2 showed increase in 41.67% of patients
with kidney stones according to the cut-off value 82.63 pg/mL
(Table 4, Figure 1). There were 85.00% of patients with kidney
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according to the cut-off value 25.28 IU/L [Cut-off values: values
above or below the mean ± 2SD], (Table 4, Figure 1). Also in
same table and ﬁgure. Xanthine oxidase activity 30.56 IU/L
(cut-off value) was less sensitive 58.33%, while serum uric acid
5.98 mg/dL was more sensitive 83.33%.
There were a signiﬁcant different correlations between
NSMCE2 with ecto-5ʹ-nucleotidasea, xanthine oxidase, uric acid
and globulin in patients with kidney stones compared to control
group (Table 5).
4. Discussion
In the clinic, over 50% of all urological patients are stone
patients. Up to the present time, it is unknown how exactly
stones form in the kidney system in addition how they can
develop to a clinically signiﬁcant size. Stones may possibly
be clinically noiseless for a long time. Though, when they
develop beyond a size of spontaneous clearance through the
urinary tract, they possibly will cause infection, obstruction,
permanent kidney damage, and ﬁnally loss of the kidney
[14]. There was a signiﬁcantly increased in serum uric acid
level when comparing patients group with control group
(Table 2). Numerous works showed the effects of uric
acid in kidney cells and hyperuricemic animal models.
Firstly, hyperuricemia induces endothelial dysfunction and
inﬂammation [15]. Also, uric acid can induce the contraction
[16] and reactive oxygen species produced in mesangial cells
[17].
As our knowledge this is the ﬁrst time the increase in ecto-5ʹ-
nucleotidase and xanthine oxidase activities in patient with
kidney stones have been described. Another study showed that
ecto-5ʹ-nucleotidase is expressed in glomeruli together with
mesangial cells, and it can contribute to the generation of
adenosine [18]. In the cortical pars recta of the proximal tubule,
ecto-5ʹ-nucleotidase staining is little but increases somewhat
towards the medullary pars recta of the proximal tubule. In the
initially loops of the proximal convoluted tubule, prominent
staining of ecto-5ʹ-nucleotidase is obvious in the luminal brush
border membrane [19]. The luminal localization of ecto-5ʹ-
nucleotidase was difﬁcult in the purine salvage pathway of the
ﬁltered or luminal nucleotides releasing that after
dephosphorylation may affect luminal adenosine
concentrations or by nucleoside carriers taken up in the brush-
border membrane [20]. On the other hand, luminal ecto-5ʹ-
nucleotidase activities yield variations in adenosine
concentrations at the basolateral sites of the tubular epithelium
and in the interstitium [21]. The ﬁbroblasts in the interstitium
of kidney produce contact with tubular cells, also form a
sheath around afferent and efferent arterioles of the
glomerulus. Under normoxic conditions the ecto-5ʹ-
nucleotidase-positive cells are exclusively located in the cortex
and cannot be demonstrated in the medulla. The concentration
of ﬁbroblast staining in the cortex alterations in parallel with
increased production of erythropoietin. Under normal
conditions, the staining is located predominantly in the deep
cortex. The staining increases, however, throughout the whole
cortex under challenges of hypobaric oxygen breathing or
anemia [22]. There were 85.00% of patients with kidney stones
who had abnormal ecto-5ʹ-nucleotidase activity values, this
ﬁnding might be due to a physiologic effects of stones
formation on glomeruli and mesangial cells, and it cancontribute to the generation of adenosine which may be lead
to increase in ecto-5ʹ-nucleotidase activity.
Xanthine oxidase is a ubiquitous complex cytosolic
molybdo-ﬂavoprotein which controls the rate limiting step of
purine catabolism by converting xanthine to uric acid [21].
Serum xanthine oxidase levels are increased in several
pathological states: inﬂammation, ischemia-reperfusion, aging
and atherosclerosis [23]. The reactive oxygen species are
involved in oxidative damage. The inhibition of this
enzymatic pathway might be beneﬁcial. Excess of uric acid,
the metabolic product of xanthine oxidase, can lead to gout
[24]. Increased in xanthine oxidase may be leads to increase
formation of uric acid and decrease of xanthine thus is present
at low concentration in the ureters and urine, and because of
its poor solubility precipitates out readily, especially in hot
climates where urine volumes are small and urine very
concentrated which leads to increased uric acid in blood. We
describe the increase in NSMCE2 in sera of patients with
kidney stones compared to control group in previous study
[25].We found in previous study that the reduction of
adenosine aminohydrolase and AMP-aminohydrolase activities
could cause a state of immune suppression, also the increase in
NSMCE2 may play a role in developments of change DNA
damage and inﬂammation disorders in the patients with kidney
stones. In the recent studies indicate a role for sumoylation in
the regulation of inﬂammation. Inﬂammation is initiated in
response to kidney tissue damage. Inﬂammatory responses must
be regulated properly, and unrestricted inﬂammation can lead to
inﬂammatory disorders in patients with kidney stones. In con-
clusions the increase in serum of NSMCE2 level, xanthine
oxidase and ecto-5ʹ-nucleotidase activities can be used as bio-
markers for diagnosis of kidney damage in patients with kidney
stone also to evaluate the increase in damage made in the DNA
and because of the active role of NSMCE2 in the treatment of
damage made in the DNA.
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